Physician profile
Shida Saam
NPI 1528099470
$3,749.54
in general payments reported to CMS, 2019-2025
37 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $797 · 2021: $1,167 · 2022: $474 · 2023: $473 · 2024: $150 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $472.46 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $436.72 | 2020-2024 | Mounjaro, Trulicity |
| Abbvie INC. | $417.73 | 2019-2021 | |
| Amgen INC. | $401.71 | 2019-2025 | Tepezza, Repatha, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.13 | 2020-2023 | Jardiance |
| Radius Health, INC. | $188.18 | 2019-2021 | |
| Pfizer INC. | $166.37 | 2019-2025 | |
| Novo Nordisk INC | $163.58 | 2020-2025 | Rybelsus, Ozempic |
| Ironwood Pharmaceuticals, INC | $140.47 | 2022-2024 | Linzess |
| Astellas Pharma US INC | $106.05 | 2020-2022 | |
| Inspire Medical Systems, INC. | $103.20 | 2025 | Inspire |
| Allergan, INC. | $93.46 | 2019-2020 | |
| Amarin Pharma, INC. | $88.62 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $56.22 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.17 | 2021-2023 | Trulance, Xifaxan |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $50.53 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.80 | 2022 | |
| Eisai INC. | $48.70 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.90 | 2019 | |
| Redhill Biopharma INC. | $44.46 | 2020-2022 | |
| Therapeuticsmd, INC. | $41.08 | 2019-2020 | |
| Horizon Therapeutics Plc | $40.51 | 2020-2021 | |
| Hologic Sales and Service, LLC | $39.87 | 2022-2023 | Aptima |
| Biohaven Pharmaceuticals, INC. | $33.82 | 2021 | |
| Merck Sharp & Dohme LLC | $26.72 | 2019-2021 | |
| Neuronetics, INC. | $22.81 | 2025 | Neurostar Tms Therapy System |
| Medtronic Vascular, INC. | $22.54 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.14 | 2021 | |
| Tonix Medicines, INC. | $20.98 | 2025 | Zembrace Symtouch |
| Glaxosmithkline, LLC. | $19.99 | 2022 | |
| Agile Therapeutics, INC. | $19.32 | 2021 | |
| Phadia US INC. | $19.08 | 2023 | Immunocap |
| Boston Scientific Corporation | $18.59 | 2020 | |
| Exact Sciences Corporation | $17.44 | 2025 | Cologuard Collection Kit |
| Endogastric Solutions, INC | $16.26 | 2019 | |
| Daiichi Sankyo INC. | $14.67 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shida Saam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.